ClinicalTrials.govpublic full text
A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes
type 1 diabetes mellitus, diabetes mellitus, residual beta cell function, hla dr3-dq2, diabetes mellitus, type 1, autoimmune diseases, metabolic disease, autoimmune diabetes, vitamin d, immune system diseases, insulin dependent diabetes, rhgad65
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 982495
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.